参考文献/References:
[1] LI Xue, LU Lihong, HOU Wenting, et al. Epigenetics in the pathogenesis of diabetic nephropathy[J]. Acta Biochimica et Biophysica Sinica(Shanghai), 2022, 54(2): 163-172.
[2] CHEN Sijie, L? Linli, LIU Bicheng, et al. Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease[J]. Cell Proliferation, 2020, 53(3): e12763.
[3] ZHANG Yang, MA Kunling, GONG Yuxiang, et al. Platelet microparticles mediate glomerular endothelial injury in early diabetic nephropathy[J]. Journal of the American Society of Nephrology, 2018, 29(11): 2671-2695.
[4] YANG Yongyu, CHEN Zhuo, YANG Xiding, et al. Piperazine ferulate prevents high-glucose-induced filtration barrier injury of glomerular endothelial cells[J]. Experimental and Therapeutic Medicine, 2021, 22(4): 1175.
[5] SHU Anmei, DU Qiu, CHEN Jing, et al. Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway [J]. Chemico-Biological Interactions, 2021, 348: 109625.
[6] FU Jianing, WU Hao. Structural mechanisms of NLRP3 inflammasome assembly and activation [J]. Annual Review of Pathology, 2023, 41: 301-316.
[7] LIU Zhiguang, ZHU Xiaochun, XU Chenglin, et al. Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathway[J]. Drug Development Research, 2023, 84(1): 36-44.
[8] XIE Shuhua,YANG Tao,WANG Zhifen, et al. Astragaloside IV attenuates sepsis-induced intestinal barrier dysfunction via suppressing RhoA/NLRP3 inflammasome signaling [J].International Immunopharmacology, 2020, 78: 106066.
[9] REN Bei, FENG Jinping, YANG Ning, et al. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway [J].International Immunopharmacology, 2021, 98: 107841.
[10] TIAN Fengyuan, WANG Xi, NI Haixiang, et al. The ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells by regulating the RhoA/ROCKs/YAP signaling pathway and cytoskeleton formation[J]. Journal of Pharmacological Sciences, 2021, 145(1): 88-96.
[11] ZHOU Tong,SUN Lin,YANG Shuo,et al. 20(S)-ginsenoside Rg3 protects kidney from diabetic kidney disease via renal inflammation depression in diabetic rats[J]. Journal Diabetes Research. 2020,2020:7152176.
[12] HU Qichao, JIANG Lan, YAN Qi, et al. A natural products solution to diabetic nephropathy therapy [J].Pharmacology & Therapeutics, 2023, 241: 108314.
[13] WU Jinshan, WANG Zhihong, CAI Minchao, et al. GPR56 promotes diabetic kidney disease through eNOS regulation in glomerular endothelial cells[J]. Diabetes, 2023, 72(11): 1652-1663.
[14] WANG Qi, REN Daijin, LI Yebei, et al. Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells[J]. Cell Cycle, 2019, 18(6/7): 696-707.
[15] YAN Qianhua, WANG Xin, ZHA Min, et al. The RhoA/ROCK signaling pathway affects the development of diabetic nephropathy resulting from the epithelial to mesenchymal transition[J]. International Journal of Clinical and Experimental Pathology, 2018, 11(9): 4296-4304.
[16] RAO Jialing, YE Zengchun, TANG Hua, et al. The RhoA/ROCK pathway ameliorates adhesion and inflammatory infiltration induced by AGEs in glomerular endothelial cells [J].Scientific Reports,2017,7:39727.
[17] WAN Jiayi, LIU Dongwei, PAN Shaokang, et al. NLRP3-mediated pyroptosis in diabetic nephropathy [J]. Frontiers in Pharmacology,2022, 13: 998574.
[18] AN Xin, ZHANG Yahui, CAO Yuan, et al. Punicalagin protects diabetic nephropathy by inhibiting pyroptosis based on TXNIP/NLRP3 pathway[J]. Nutrients, 2020, 12(5): 1516.
[19] 杨宏秀, 刘丽, 张会芬, 等. 血清抗中性粒细胞胞浆抗体及相关炎性因子检测对糖尿病肾病的诊断价值[J].现代检验医学杂志,2018,33(5):95-97, 101. YANG Hongxiu, LIU Li, ZHANG Huifen, et al. Diagnostic value of detection anti-cardiolipin antibodies and related inflammatory factors in diabetic nephropathy[J]. Journal of Modern Laboratory Medicine, 2018, 33(5): 95-97, 101.
[20] CHEN Zhida, WANG Zhe, HU Yepeng, et al. ELABELA/APJ axis prevents diabetic glomerular endothelial injury by regulating AMPK/NLRP3 pathway[J]. Inflammation, 2023, 46(6): 2343-2358.
[21] DRI E, LAMPAS E, LAZAROS G, et al. Inflammatory mediators of endothelial dysfunction[J]. Life-basel, 2023, 13(6): 1420.
[22] TANG Guoyi, LI Sha, ZHANG Cheng, et al. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management[J]. Acta Pharmaceutica Sinica. B, 2021, 11(9): 2749-2767.
[23] SUI Zhe, SUI Dayun, LI Min, et al. Ginsenoside Rg3 has effects comparable to those of ginsenoside re on diabetic kidney disease prevention in db/db mice by regulating inflammation, fibrosis and PPARγ[J].Molecular Medicine Reports, 2023, 27(4): 84.
相似文献/References:
[1]张春雷,曾学辉,李忠新,等.尿KIM-1和NGAL在糖尿病肾病早期诊断中的应用[J].现代检验医学杂志,2015,30(01):52.[doi:10.3969/j.issn.1671-7414.2015.01.014]
ZHANG Chun-lei,ZENG Xue-hui,LI Zhong-xin,et al.Value of Urinary KIM-1 and NGAL
in Predicting the Early Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2015,30(02):52.[doi:10.3969/j.issn.1671-7414.2015.01.014]
[2]阿地拉·阿布里孜,王 霞,屈晓威.联合检测视黄醇结合蛋白和膜联蛋白A2水平对糖尿病肾病早期诊断的意义[J].现代检验医学杂志,2016,31(05):118.[doi:10.3969/j.issn.1671-7414.2016.05.033]
ADILA·Abulizi,WANG Xia,QU Xiao-wei.Significance of Combined Detection of Serum Retinol-Binding
Protein and AnnexinA2 in Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2016,31(02):118.[doi:10.3969/j.issn.1671-7414.2016.05.033]
[3]于菲菲,庞白冰,杨 华,等.单纯性2型糖尿病与糖尿病肾病患者尿液中α1-微球蛋白和激肽原1的表达分析[J].现代检验医学杂志,2017,32(05):94.[doi:10.3969/j.issn.1671-7414.2017.05.017]
YU Fei-fei,PANG Bai-bing,YANG Hua,et al.Expression Analysis of α1-Microglobulin,Kininogen1
in Urine of Simple Type 2 Diabetes and Diabetic Nephropathy Patients[J].Journal of Modern Laboratory Medicine,2017,32(02):94.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[4]吴忠璟,陈亚凤,高芳虹.糖尿病肾病患者血清miR-135b水平检测与疾病预后的相关性研究[J].现代检验医学杂志,2018,33(03):88.[doi:10.3969/j.issn.1671-7414.2018.03.022]
WU Zhong-jing,CHEN Ya-feng,GAO Fang-hong.Correlation between Serum miR-135b Level and Prognosis
in Patients with Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2018,33(02):88.[doi:10.3969/j.issn.1671-7414.2018.03.022]
[5]杨翠伶.血清miR-150-5p和miR-155-5检测对老年糖尿病肾病的诊断价值[J].现代检验医学杂志,2018,33(05):74.[doi:10.3969/j.issn.1671-7414.2018.05.020]
YANG Cui-ling.Diagnostic Value of Serum miR-150-5p and miR-155-5 Detection in Elderly Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2018,33(02):74.[doi:10.3969/j.issn.1671-7414.2018.05.020]
[6]谭志敏,张 燕,滕雅娟,等.糖尿病肾病患者血清甲状腺激素水平变化及其与亚临床甲状腺功能减退的相关性[J].现代检验医学杂志,2018,33(06):95.[doi:10.3969/j.issn.1671-7414.2018.06.025]
TAN Zhi-min,ZHANG Yan,TENG Ya-juan,et al.Correlation between Serum Thyroid Hormone Levels in Patients with Diabetic Kidney Disease and Subclinical Hypothyroidism[J].Journal of Modern Laboratory Medicine,2018,33(02):95.[doi:10.3969/j.issn.1671-7414.2018.06.025]
[7]张求霞a,汪隆海a,昌国庆a,等.尿液6种蛋白与CysC水平检测对糖尿病肾病的诊断价值[J].现代检验医学杂志,2019,34(01):67.[doi:10.3969/j.issn.1671-7414.2019.01.017]
ZHANG Qiu-xiaa,WANG Long-haia,CHANG Guo-qing
a,et al.Clinical Value of Detection of 6 Proteins and Cystatin C
in Urine for Early Diagnosis of Diabetic Kidney Disease[J].Journal of Modern Laboratory Medicine,2019,34(02):67.[doi:10.3969/j.issn.1671-7414.2019.01.017]
[8]张曙晴,张骆军,李洪彬,等.血液小而密低密度脂蛋白胆固醇、抗凝血酶Ⅲ水平及血小板参数检测在2型糖尿病肾病中的应用价值研究[J].现代检验医学杂志,2021,36(02):70.[doi:doi:10.3969/j.issn.1671-7414.2021.02.017]
ZHANG Shu-qing,ZHANG Luo-jun,LI Hong-bin,et al.Study on the Application Value of Detecting Small Dense Low-density Lipoprotein Cholesterol, Antithrombin-Ⅲ Levels and Platelet Parameter in the Patients with Type-2 Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2021,36(02):70.[doi:doi:10.3969/j.issn.1671-7414.2021.02.017]
[9]闫海燕,杨云秀,杨云华,等.老年糖尿病肾病患者血清SP-D水平表达及其基因多态性与并发肺部感染的相关性研究[J].现代检验医学杂志,2021,36(04):21.[doi:10.3969/j.issn.1671-7414.2021.04.005]
YAN Hai-yan,YANG Yun-xiu,YANG Yun-hua,et al.Research on the Relationship between Serum SP-D Level, Gene Olymorphismand Pulmonary Infection in Elderly Patients with Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2021,36(02):21.[doi:10.3969/j.issn.1671-7414.2021.04.005]
[10]祁桠楠a,胡江伟b,武 亮c,等.血清TLR-3，miR-181b及URBP联合检测在糖尿病肾病诊断及预后判断的价值研究[J].现代检验医学杂志,2022,37(02):37.[doi:10.3969/j.issn.1671-7414.2022.02.008]
QI Ya-nana,HU Jiang-weib,WU Liangc,et al.Value of Combined Detection of Serum TLR-3, miR-181b and URBP in Diagnosis and Prognosis of Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2022,37(02):37.[doi:10.3969/j.issn.1671-7414.2022.02.008]